Loading BioAtlas...
Loading BioAtlas...
Compare biological models, docking engines, and computational workflows side-by-side. Filter by access model, compute footprint, and category to reach an actionable decision table in under a minute.
| Attribute | Drug Discovery & Chemistry Schrödinger Maestro & Computational Chemistry SuiteSchrödingerCommercial⚡ A100/H100 | ＋ Add tool |
|---|---|---|
| Category | Drug Discovery & Chemistry | — |
| Subcategory | Physics & AI Drug Design Platform | — |
| Company | Schrödinger | — |
| Access mode | Commercial License | — |
| Licence conditions | Proprietary commercial license | — |
| Compute requirements | Workstation / high-performance GPU cluster (CUDA-enabled) | — |
| Biological application | Small-molecule drug discovery, structure-based design, and ADMET profiling | — |
| Research workflow | Hit-to-lead and lead optimization via FEP+ calculations and docking | — |
| Evidence level | Extensive peer-reviewed validation across hundreds of biopharma programs | — |
| Commercial eligibility | Commercial enterprise licensing | — |
| Price | Enterprise license — contact vendor | — |
| Availability ⓘ | Globally available for commercial and academic institutions | — |
| Features | Industry-leading FEP+ for predicting relative and absolute protein-ligand binding free energies, Glide docking engine with induced-fit and deep-learning scoring options, Maestro 3D visual modeling and pharmacophore hypothesis generation, Active learning molecular property prediction across multi-billion compound spaces | — |
| Entry type | Commercial Software | — |
| AI role | Physics & ML Hybrid Modeling | — |
| Input data | Not recorded | — |
| Output data | Not recorded | — |
| Validation | Not recorded | — |
| Type | Enterprise computational chemistry platform | — |
| Intended use | Not recorded | — |
| Compatibility | Not recorded | — |
| Manufacturer | Schrödinger, Inc. | — |
| Integration evidence | https://www.schrodinger.com/platform/products/maestro/ | — |
| Laboratory handoff | Direct compound prioritization for chemical synthesis and enzymatic assays | — |